In a filing, BeOne Medicines Ltd ADR revealed its SVP, General Counsel Lee Chan Henry unloaded Company’s shares for reported $0.22 million on Jan 07 ’26. In the deal valued at $331.76 per share,664 shares were sold. As a result of this transaction, Lee Chan Henry now holds 0 shares worth roughly $0.0.
Then, OYLER JOHN sold 75,631 shares, generating $23,278,679 in total proceeds. Upon selling the shares at $307.79, the Chief Executive Officer now owns 24,369 shares.
Before that, OYLER JOHN sold 24,369 shares. BeOne Medicines Ltd ADR shares valued at $7,380,739 were divested by the Chief Executive Officer at a price of $302.87 per share. As a result of the transaction, OYLER JOHN now holds 0 shares, worth roughly $0.0.
Truist initiated its BeOne Medicines Ltd ADR [ONC] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. RBC Capital Mkts began covering ONC with “an Outperform” recommendation on April 07, 2025. BofA Securities revised its rating on March 03, 2025. It rated ONC as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ONC
On Monday, BeOne Medicines Ltd ADR [NASDAQ:ONC] saw its stock jump 5.47% to $337.89. Over the last five days, the stock has gained 8.64%. BeOne Medicines Ltd ADR shares have risen nearly 92.97% since the year began. Nevertheless, the stocks have risen 11.22% over the past one year.
How much short interest is there in BeOne Medicines Ltd ADR?
A steep rise in short interest was recorded in BeOne Medicines Ltd ADR stocks on 2025-12-15, dropping by 28147.0 shares to a total of 1.3 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 1.33 million shares. There was a decline of -2.16%, which implies that there is a negative sentiment for the stock.
